A phase II study of Avelumab + stereotactic ablative body radiosurgery (SABR) for metastatic castration-resistant prostate cancer (mCRPC)

  • Kwan, Edmond (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/17/MonH/29
NMA SSA Reference Number: SSA/17/MonH/289
Monash Health Ref: 17-0000-082A

StatusActive
Effective start/end date4/01/193/01/24